Angioedema associated with Crohn's disease: response to biologics
Case report
OA: hybrid
CC0
Abstract
A 46-year-old female patient with terminal ileum Crohn's disease and ankylosing spondylitis presented with recurrent angioedema and urticaria. Investigations ruled out hereditary angioedema, and environmental or food allergen triggers. She was diagnosed with chronic idiopathic urticaria with angioedema, and was treated with a trial of intravenous immunoglobulin immunotherapy, danazol, prednisone and hydroxyzine. Due to ongoing bowel and arthritic complaints, she was started on infliximab infusions and within 2 treatments, she had complete resolution of the angioedema and urticaria, as well as of the bowel and arthritic symptoms. Unfortunately she developed allergic reactions to the infliximab and was switched to another anti-tumor necrosis factor (TNF)-α agent, adalimumab. Since then, she has had no further angioedema or urticaria, and her Crohn's disease has been quiescent. This is the first known case report of chronic idiopathic urticaria with angioedema coexistent with Crohn's disease that was successfully treated with anti-TNF-α agents.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (21)
- doi:10.1053/j.gastro.2011.02.016 via openalex
- doi:10.1111/j.1365-2222.2009.03256.x via openalex
- doi:10.1136/bcr.08.2008.0781 via openalex
- doi:10.1016/j.intimp.2008.05.016 via openalex
- doi:10.1111/j.1445-5994.2008.01673.x via openalex
- doi:10.2500/aap.2009.30.3188 via openalex
- doi:10.1053/j.gastro.2010.12.002 via openalex
- W6671071868 via openalex
- doi:10.1016/j.jaci.2006.12.658 via openalex
- doi:10.5694/j.1326-5377.1999.tb123722.x via openalex
- doi:10.1155/2000/414107 via openalex
- doi:10.2500/aap.2009.30.3191 via openalex
- doi:10.1016/j.gtc.2010.08.018 via openalex
- doi:10.1038/ajg.2011.73 via openalex
- doi:10.1155/2000/828679 via openalex
- doi:10.1007/s12253-011-9397-4 via openalex
- doi:10.1016/s1081-1206(10)62898-0 via openalex
- doi:10.1016/s0140-6736(08)60995-2 via openalex
- doi:10.3748/wjg.14.5154 via openalex
- doi:10.3109/08820139909022722 via openalex
- doi:10.1016/s0091-6749(99)70506-3 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T05:37:28.352103+00:00
- pubmed
- last seen: 2026-10-08T21:10:53.858194+00:00
License: CC0
· commercial use OK